Crossref
Immunological implications of the use of tyrosine kinase inhibitors in chronic myeloid leukemia
Journal of Hematological Malignancies · 2012
DOI: 10.5430/jhm.v2n3p45 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hematological Malignancies, 2012. Verfasst von Camila De Souza Rodrigues und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rodrigues, C. D. S., Mendonça, L. M., Oliveira, J. R. D., Napimoga, M. H., & Abreu, M. T. C. L. (2012). Immunological implications of the use of tyrosine kinase inhibitors in chronic myeloid leukemia. Journal of Hematological Malignancies. https://doi.org/10.5430/jhm.v2n3p45
Vancouver
Rodrigues CDS, Mendonça LM, Oliveira JRD, Napimoga MH, Abreu MTCL. Immunological implications of the use of tyrosine kinase inhibitors in chronic myeloid leukemia. Journal of Hematological Malignancies. 2012. doi:10.5430/jhm.v2n3p45
BibTeX
@article{Rodrigues2012,
author = {Rodrigues, Camila De Souza and Mendonça, Larine Miranda and Oliveira, Jhony Robison de and Napimoga, Marcelo Henrique and Abreu, Maria Theresa Cerávolo Laguna},
title = {Immunological implications of the use of tyrosine kinase inhibitors in chronic myeloid leukemia},
journal = {Journal of Hematological Malignancies},
year = {2012},
doi = {10.5430/jhm.v2n3p45}
}
EUVIMED